Remedy Pharmaceuticals Secures Key U.S. Patent Allowance for CIRARA® in Treating Large Hemispheric Infarction, Including Wake-Up Strokes
Remedy Pharmaceuticals, a leader in stroke drug development, today announced that the U.S. Patent and Trademark Office (USPTO) has allowed two additional patents covering its large hemispheric ...
Medscape8d
A Case of Acute Ischemic Stroke: Optimizing Management with Penumbra and Vessel Imaging
On arrival (3 h 17 min after symptom onset) the patient remained globally aphasic with dense right hemiparesis and hemisensory loss; her score on the NIH stroke scale was 24, which indicated a ...
Pulmonology Advisor7d
TNKase Approved for Treatment of Acute Ischemic Stroke
The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.
Healio1mon
Neural stem cell transplant improves outcomes for chronic ischemic stroke at 12 months
Secondary outcomes included performance on a gait speed test, Barthel Index (BI), NIH Stroke Scale score (NIHSS), Fluid-attenuated inversion recovery (FLAIR) MRI, resting state fMRI and ...